Conduction System Pacing Clinical Trials
2 recruiting trials for Conduction System Pacing. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Conduction System Pacing clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by The First Affiliated Hospital with Nanjing Medical University (1), Abbott Medical Devices (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Conduction system pacing (device, 1 trial), followed by Biventricular pacing, LBBAP lead.
Track Conduction System Pacing trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
CSP Versus BiVP for Heart Failure Patients With RVP Upgraded to Cardiac Resynchronization Therapy
The present study is a prospective, multicenter, non-inferiority, randomized controlled trail. It aims to investigate whether the efficacy of conduction system pacing (CSP) is...
Left Bundle Branch Area Pacing (LBBAP) PMCF Study
The objective of this study is to evaluate the safety and effectiveness of LBBA pacing/sensing in patients implanted with the Tendril STS 2088TC or UltiPace LPA1231 lead through 6...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Conduction System Pacing, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Conduction System Pacing, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Conduction System Pacing, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.